GUARDANT HEALTH INC

Guardant Health stock swings 5.9% lower, yet rises 2.5% today amid executive share buys and no new deals, raising questions about future growth.

Guardant Health (GH) climbs 2.98% on a bullish platform, expanding liquid biopsy panels, forming payer partnerships, and riding FDA‑friendly momentum for long‑term upside.

Guardant Health shares dip 0.45% as insiders buy RSUs—stable cash, growing client base, and liquid biopsy leadership keep long‑term upside strong.